Advancing mAb Stability Studies With Mass Photometry
Introducing a new bioanalytical technology for assessing monoclonal antibody (mAb) sample quality from early-stage candidate selection to manufacturability evaluation - mass photometry.
In this webinar, you’ll discover how mass photometry can be used for forced antibody degradation assessment, a crucial aspect of research and development for recombinant mAb therapeutics. Our expert speaker will also demonstrate how mass photometry data compares to and complements the current gold standard, size exclusion chromatography (SEC), as well as providing insights into other applications of mass photometry in therapeutic antibody R&D labs.
Attend this webinar to discover:
- How mass photometry enables rapid assessment of sample quality
- How mass photometry complements other analytical methods for antibody sample characterization, such as SEC
- What the sample requirements are for detection of antibody aggregates and fragments
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
